Key facts
- Notable investors include Fresh.Fund, Meta AI Accelerator.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Elpida (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for Elpida (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elpida (Business/Productivity Software)
Developer of an AI-powered compliance platform designed to ensure regulatory adherence across healthcare marketing communications. The company offers multimodal analysis of video, image, and text content, real-time risk scoring with automated validation, pre-vetted audience generation, and compliance-checked messaging tools, enabling pharmaceutical brands, healthcare agencies, and health startups to launch campaigns confidently while protecting brand reputation and accelerating approval workflows.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2025
- Employees
- 9
- Website
- getelpida.com/
- Ownership
- Privately Held (backing)
Elpida (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elpida (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elpida (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.